LETYBO

Live / Registered — Registered (as of 27 Oct 2020)

What this means for you

Registered since 27 Oct 2020. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number: 79266012
Registration number: 6181983
Mark type: Stylized text
Filed: 13 Jun 2019
Published for opposition: 11 Aug 2020
Registered: 27 Oct 2020
Attorney of record: James R Menker

Goods and services

Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of spasm; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical products for skin care for animals; pharmaceutical preparations used in cosmetic surgery; pharmaceutical preparations containing botulinum toxin; botulinum toxin for medical use for use in the treatment of neuropathy pain; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; pharmaceutical preparations for use in treating urogenital system diseases and conditions, namely, overactive bladder and urinary incontinence; bacterial toxins, namely, bacterial poisons; pharmaceutical preparations for digestive system; pharmacological preparations for skin care; pharmaceutical preparations for treating peripheral neurological diseases and disorders; pharmaceutical preparations for treating central neurological diseases and disorders; ophthalmic preparations for use in the treatment of blepharospasm and strabismus; medicated ointments for treating dermatological conditions; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; chemical preparations for [ phamaceutical ] * pharmaceutical * purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical agents for epidermis; drugs for medical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; biological preparations for medical or veterinary purposes for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; cultures of microorganisms for medical or veterinary use; chemical reagents for medical or veterinary purposes; bacteriological preparations for medical and veterinary use; adjuvants for medical purposes; hyaluronic acid preparations for medical purposes; medicines for human purpose, namely, medicines for skin care; pharmaceutical preparations for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for the treatment of orthopaedic disorders, namely, hip dislocation, spinal column deformation, curvature of the spine, namely, scoliosis, lordosis, cyphosis; pharmaceutical preparations for smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, tremors and pain; pharmaceutical preparations for the treatment of wrinkles; injectable dermal filler; medicines for dental purposes; preparation for the relief of pain; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations mainly based on hyaluronic acid for treatments, namely, injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; botulinum toxin for medical use for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders; therapeutic drugs and agents for use in the treatment of excessive sweating, excessive eye blinking, neuropathy pain, facial wrinkles, headache, pain, spasm, dystonia, urogenital system diseases and conditions, skin disorders

Owner

Prosecution history

27 Oct 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13 Aug 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
21 Feb 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
05 Feb 2025 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
12 Dec 2024 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
21 May 2024 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
12 Apr 2024 — CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
11 Apr 2024 — CORRECTION UNDER SECTION 7 - PROCESSED
17 Mar 2024 — CORRECTION TRANSACTION RECEIVED FROM IB
07 Mar 2021 — FINAL DECISION TRANSACTION PROCESSED BY IB
27 Feb 2021 — NEW REPRESENTATIVE AT IB RECEIVED
06 Feb 2021 — FINAL DISPOSITION NOTICE SENT TO IB
06 Feb 2021 — FINAL DISPOSITION PROCESSED

View this trademark record on Marksy